The results of the first report of Iran's population-based cancer registry (PBCR) has been accepted for reporting in Globocan 2012 by the International Agency for Research on Cancer (IARC)
The results of the first report of Iran's population-based cancer registry (PBCR) has been accepted for reporting in Globocan 2012 by the International Agency for Research on Cancer (IARC).
Based on this report, 112,000 cancers occur in Iran annually. This is the first report with high quality data from Iran. The incidence rate of cancer is lower than the world's average. This report was prepared and presented based on the agreement and support of three deputies in the Ministry of Health and Medical Education including Deputy of Research, Deputy of Public Health, and Deputy of Treatment as well as the cancer registries offices in 50 medical universities in Iran. This report is based on data from all the country and covers 98% of the Iranian population. Overview on the results of the first report of the population-based cancer registry (PBCR): Annual age standardized incidence rate of cancer in Iran was 143 per 100,000 per year ( excluding non-melanoma skin cancer) which is lower than the rate in the world on average (ASR 182 per 100,000 per year), Europe (ASR. 267 per 100,000 per year), UK (ASR 272 per 100,000), the United States (ASR 318 per 100,000 per year), China (ASR 174 per 100,000), and Turkey (ASR 205 per 100,000).
The most common cancers among Iranian males include stomach cancer (ASR 21.5 per 100,000 per year) skin cancer (ASR 20.5 per 100,000), prostate cancer (ASR 18.5 per 100,000), colorectal cancer (16.5 per 100,000), bladder cancer (14.3 per 100,000) and among women include breast cancer (ASR 34.5 per 100,000 per year) skin cancer (ASR 11.5 per 100,000), stomach cancer (ASR 10 per 100,000), and thyroid cancer (7 per 100,000 per year). The most lethal cancers in Iran in 2016 was cancers of gastric, lung, leukemia, esophagus, colon, brain and nervous system, breast, prostate, liver and pancreas.
Problem in the registration system in the past, improvement in the diagnosis of cancer and histopathologic examination of the cases, aging of the Iranian population and improvement in the life expectancy in both men and women has led to increase in the cancer incidence and mortality rate in Iran.